NASDAQ: STTK - Shattuck Labs, Inc.

Yield per half year: +225.65%
Sector: Healthcare

Share chart Shattuck Labs, Inc.


About

Shattuck Labs, Inc., биотехнологическая компания на клинической стадии, разрабатывает терапевтические средства для лечения рака и аутоиммунных заболеваний в Соединенных Штатах. Ведущим кандидатом на продукт компании является SL-172154, который находится в фазе 1 клинических испытаний для лечения рака яичников. Он также заключил соглашение о сотрудничестве с Takeda Pharmaceuticals для разработки SL-279252, который находится в стадии 1 клинических испытаний у пациентов с прогрессирующими солидными опухолями и лимфомой. Компания была основана в 2016 году со штаб-квартирой в Остине, штат Техас.


Main settings

P/S 210.73
EV/EBITDA 0.2991
EBITDA -0.0234
Цена ао 10.42
Сайт http://www.shattucklabs.com
P/BV 6.76
Число акций ао 0.0426 млрд
Выручка 0.0099
Див.доход ао 0
ISIN US82024L1035
Change price per day: 0% (7.49)
Change price per week: -5.37% (7.915)
Change price per month: -24.34% (9.9)
Change price per 3 month: -20.82% (9.46)
Change price per half year: +225.65% (2.3)
Change price per year: +160.98% (2.87)
Change price per 3 year: -67.42% (22.99)
Change price per year to date: +13.48% (6.6)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 210.73 1
P/BV 6.76 7
P/E 0 0
EV/EBITDA 0.2991 0
Total:

Efficiency

Title Value Grade
ROA, % -47.85 0
ROE, % -54.41 0
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA -0.0478 10
Total:

Growth impulse

Title Value Grade
Profit growth, % 26.77 5
Share price growth, % -311.73 0
Dividend growth, % 0 0
Total:

Insider trading

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
28.01.2022 31.01.2022 Schreiber Taylor
Chief Executive Officer
Buy 4.67 18 334 3926 0 0.01 link
19.01.2022 19.01.2022 Brous Tyler
Director
Buy 6.87 20 610 3000 0 0.01 link
12.01.2022 12.01.2022 Thomson Erin Ator
General Counsel
Buy 2.95 29 500 10000 0 0.02 link

Main owners

Institutions Volume Share, %
FMR, LLC 7071174 14.89
Redmile Group, LLC 5619914 11.84
Prosight Management, LP 2782797 5.86
Adage Capital Partners GP L.L.C. 1752705 3.69
Franklin Resources, Inc. 1635821 3.45
Clark Estates Inc. (The) 1475648 3.11
Vanguard Group Inc 1317066 2.77
Point72 Asset Management, L.P. 670435 1.41
Laurion Capital Management, LP 661038 1.39
Maven Securities Limited 633876 1.34

Similar companies



Company management

Head Job title Payment Year of birth
Dr. Arundathy Nirmalini Pandite M.B.A., M.D. Chief Medical Officer 678.76k 1960 (64 years)
Ms. Casi DeYoung Chief Business Officer 523.48k 1971 (53 years)
Mr. Andrew R. Neill M.B.A. Chief Financial Officer N/A 1986 (38 years)
Dr. Abhinav A. Shukla Ph.D. Chief Technical Officer 567.4k 1973 (51 year)
Dr. Thomas Lampkin Pharm.D. Senior Vice President of Regulatory Affairs N/A
Dr. Taylor H. Schreiber M.D., Ph.D. Co-Founder, CEO & Director 783.75k 1980 (44 years)
Mr. Conor Richardson CPA Vice President of Investor Relations N/A
Mr. George Fromm Ph.D. Chief Scientific Officer of ARC Platform N/A
Mr. Suresh de Silva Ph.D. Chief Scientific Officer of GADLEN Platform N/A
Dr. Stephen Stout J.D., Ph.D. General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer N/A

About company

Address: United States, Austin, TX , 1018 West 11th Street - open in Google maps, open in Yandex maps
Website: http://www.shattucklabs.com
Phone: +919 864 2700